With these data, patients may tune in the administration of doses, avoiding physiological complications arising from an excess of insulin. In four years it is expected that the technology is available on the market. Scientists say it is very necessary because diabetes is increasingly present in our society as a result of lifestyle we lead. For Yaiza Martínez.

Diabetics can reduce the amount of insulin that administrate with the help of a new portable and wireless device designed to predict blood glucose levels.

This device, known as “DIAdvisor ™” will be developed by the company Toumaz Technology, specializes in manufacturing wireless devices and low power consumption to control the body. The project falls under the Seventh Framework Program of the European Community, which has earmarked 7.1 million euros.

The purpose of development of this device is to improve the lives of millions of diabetes patients, with an art tool for personalized prediction of blood glucose levels, reports Toumaz Technology in a statement.

The tool will be created thanks to a partnership of 13 doctors and several industry partners and academics. The work will be coordinated by Novo Nordisk company specializing in the care of this disease.

What is

DIAdvisor technology (Personal Glucose Predictive Diabetes Advisor) will be based on a wireless control technology of the body, existing and belonging to the company Toumaz Technology Sensium call.

Sensors consist of small, wireless and discreet, surrounded by a silicium chip low-power, which will stick to the body of the sick to log certain data, such as body temperature, blood pressure, blood glucose levels or oxygen, among other parameters.

According to The Engineer magazine reported online, the system transmits this data to a portable mobile device like a PDA or PDA. By hand, it may also introduce any other information you want, like food that has consumed the patient.

All these data will be analyzed later by an advanced algorithm to determine glucose levels in the patient’s blood at any particular time. In this way, patients will know in a matter of minutes, the amount of insulin will be administered at the next dose.

Breakthrough
According to Keith Errey, co-founder and president of Project Toumaz, current techniques for managing diabetes does not offer the ability to predict blood glucose levels in the short term. This means that patients should almost assume the amount of insulin they need to recover the stable levels of blood glucose.

Scientists hope, moreover, that this technology serves to avoid the risk of blackouts suffered by diabetics when their blood sugar levels drop dramatically. Many of the sick, in fact, prefer to consume higher doses of insulin than necessary to avoid the crisis, but the excess insulin also has its risks, including possible damage to the eyes, heart or liver.

But before he can see the light DIAdvisor are still important steps to take, how to define the combination of vital signs that provide the best information to determine the blood glucose level. For this, scientists will have a team of volunteers with diabetes to help generate the physiological models and prediction algorithms.

Within two years, will begin clinical trials in which they will operate these algorithms in real time and test the prediction models. If everything runs according to plan for the scientists, the technology will be available in the market within four years.

Technology increasingly necessary
According to published Toumaz, the massive increase in the incidence of diabetes is now a major global health challenges. This increase is due to demographic trends clear, as the epidemic of obesity, aging, or the spread of sedentary lifestyles.

All these factors have caused a massive spread of diabetes, especially type 2. In the case of type 1 diabetes, the pancreas does not produce insulin, but in the pancreas of type 2 if that makes it, but the body assimilates as it should.

Consequently, the pancreas produces more insulin to get glucose into cells, and just exhausted due to excessive strain. In addition, blood sugar levels get too high.

In the European Union, the average prevalence of this disease is 7.5% but is expected to increase to 16% in 2025. Scientists hope that, with DIAdvisor, it can provide a sophisticated treatment of the sick, thus enhancing self-management of disease and reduce the risk of serious complications resulting from poor control of glucose levels in the blood.

Stergiou of Sotiria Hospital of Athens (Greece) and colleagues assessed the automatic device in 73 people: 27 with atrial fibrillation, 23 with arrhythmia other than atrial fibrillation and 23 reference persons in sinus rhythm.

Overall, rose to 217 blood pressure measurements, all with simultaneous ECG monitoring.

The authors note that when the diagnosis of atrial fibrillation was based in a single measurement, the sensitivity of the algorithm was 93% and specificity of 89%.

Under optimal circumstances (three measurements with at least two to diagnose atrial fibrillation) the sensitivity was 100% and specificity of 89%, indicating a “near perfect match” with the electrocardiograph diagnosis.

Under these optimal circumstances (diagnosis based on two measurements at least three positive) diagnosis of atrial fibrillation was incorrect in five people.

In all these cases, patients had arrhythmia other than atrial fibrillation in the three measurements.

Dr. Stergiou told Reuters Health that long-term self-monitoring of hypertensive patients using a device equipped with an atrial fibrillation detector would allow an earlier diagnosis without additional screening costs.

He added that the “implementation of this technology should be evaluated in other devices for measuring blood pressure and for ambulatory blood pressure monitoring 24-hour blood pressure (especially in patients with intermittent atrial fibrillation), which could also contribute to Early detection of undiagnosed atrial fibrillation and therefore the prevention of stroke. ”

“Additional research is needed on the accuracy of electronic blood pressure monitors in patients with atrial fibrillation, aimed at improving the treatment of hypertension in these patients.”

In a study of 250 Danish adults stricken by a heart attack, Canadian researchers used a tensiometer to intermittently block the blood flow to an arm, an intervention that is started when the patient is transported to hospital by ambulance.

This intervention was developed by the Sick Kids Hospital in Toronto. It greatly limit the damage to heart muscle when a heart artery is blocked.

The sphygmomanometer is inflated for five minutes, then deflated for five minutes, the sequence is repeated four times. The operation lasts between 35 and 40 minutes.

Once at the hospital, the patient receives a typical treatment for a heart attack, including an angioplasty in which an inflatable balloon is used to open an artery blocked or obstructed.

The study, to be published Friday in the prestigious British medical journal The Lancet, says that patients who took the blood pressure response with the sustained 30 percent less damage to heart muscle compared to those who have not received this treatment.

The damage was even reduced by 50 per cent among patients who suffered heart attacks the most devastating.

A leading researcher, Dr. Andrew Redington of Sick Kids, said that the idea behind this technique has been circulating for about 25 years.

When tissues are deprived of blood and oxygen intermittently, he said, it seems to prepare for a more prolonged interruption and a protective substance began to circulate in the body. And as the substance spreads throughout the body, it protects all the organs including the heart.

If Dr. Redington was encouraged by these results, it warns that further studies should be conducted even before the intervention becomes common practice.

His team is developing a particular automated blood pressure monitor that would make intervention easier and more efficient for staff health.

Incoming search terms for the article:

The system check-ups Mobile Tempus IC is able to tell the crew instructions on its use through its color screen.

The Tempus IC is able to perform basic medical tests such as blood pressure, pulse and an electrocardiogram.

This information will be forwarded to “a medical team consisting of experts in medical assistance in flight”.

This system check-up includes merme a camera so that the cabin crew can send pictures of a patient.

According to Captain Richard Hill, who works for Etihad, the system will quickly assess the health of a patient in a medical emergency.

“This will enable us to ensure that a passenger receives treatment appropriate to the aircraft landing in case of diversion or landing safely ‘ex, that he.

Tempus The system was designed and built by the English company and RTD will be installed on the Airbus A340 and Boeing 999 to the company before being deployed on the entire fleet of Etihad.

Thus the blood pressure but can be successful and will be sent to exact values, certain guidelines are met. Is always measured on the inside of the wrist. The cuff is applied to the artery. To obtain accurate measurement data, it is necessary to first consider the wrist at heart level to. The short time that requires a blood pressure measurement should be spent in silence. That is, it is a relaxed position – for example, sitting or lying position to take -. Nor can it be said, to avoid incorrect measurements during the measurement. Fairs give instructions on how to correct the manuals of the wrist blood pressure monitors that are located in the packaging of products.

The calculated pressure is shown on a display. There appear several levels – firstly, the systolic, upper blood pressure and secondly, the diastolic, the lower pressure. In addition, modern digital blood pressure monitors also indicate the pulse rate.